The Indian Society of NeuroOncology (ISNO) is truly well established and continues its quest with a view to promote and advance the scientific knowledge and research in tumours arising from the nervous system. Dissemination of evidence based knowledge and progress within the neuro-oncology community especially in the existing heterogeneous health care systems in our country remains one of the main aims of the society. Generating quality data from vast pool of patient numbers and excellent expertise is also an enormous challenge, which the society has managed to achieve to some extent and will continue to be one of the main thrusts in the coming years. Eventually we are striving to help our patients (the ultimate beneficiary) even better, especially in our diverse set up.
Having been involved from right at the very conceptualization, initiation, early years and now the present consolidation of ISNO has been source of personal delight and some sense of fulfilment. The society has carved a distinct niche with being the premier society representing neuro oncology in India but also as a well recognised member in Asia and at a global level. While the membership of the society has been growing steadily over the years, the major strength has been the true multi disciplinary flavour the society has managed right from its inception, being reflected in the background and specialities from which it draws its members, executive committees, presentations in annual conferences and regional chapter meetings. It is particularly thrilling to witness the excellent cooperation of mainstream clinical branches of neurosurgery and clinical oncology with colleagues from neuropathology, basic sciences and growing impact of molecular biology and other allied fields under the ISNO platform. Recent initiatives of national guidelines under a designated ISNO expert panel on medulloblastomas in 2015-16 and now on the role of molecular diagnostics as per the recent 2016 WHO classification during 2016-17 are notable and will address a much needed gap in the country. That the guidelines will be on a tier basis to allow clinicians and diagnosticians to formulate their practices as per the local resources and need and yet adhere as closely as possible to the evidence based and global/ national recommendations. Latest updates and state of the art work is regularly discussed in the society’s annual meetings, which are looked forward and well attended. We need to strengthen our regional groups to continue the educational and CME activities.
I am grateful to all my preceding presidents for contributing in their own unique way significantly in shaping up the society’s growth and will continue to strive in fulfilling the aims and objectives which we have entrusted before us.
We have managed in the also few years to get reasonable funding for our young budding doctors and scientists in any field pertaining to neuro oncology to avail of several fellowships and awards to be given away on an annual basis. May I request all of you to kindly spread this message and we look forward to receive appropriate applications for the same? All details are available on the newly revamped and informative website. I will also urge you to kindly contribute to the ‘Clinical Forum’ section, which could include an interesting case, latest updates and key data from our country and other parts of the world and should hopefully serve as a useful platform for members to get latest and relevant information.
The next 2017 annual conference of the society is being held in Bengaluru (in Nimhans convention centre) on march 10-12, 2017 and is likely to continue the theme of the rapidly evolving WHO classification and integrated diagnostics of various brain tumours and more importantly, their impact in day to day practice. It is likely going to be an extremely informative meeting and the organisers (Kidwai Memorial team) are leaving no stone unturned to get top and leading national and international experts (some of them already confirmed) for this exciting meeting. Please mark the dates and plan your calendars accordingly. There is a good likelihood we may well finally initiate some sort of national cooperative study, at least in 1-2 sites/subjects, so much needed and do-able, given the wealth of experience and large number of patients that we have. Next year will be also the turn to have the World Federation of Neuro Oncology (WFNO) meeting, held once every 4 years (ASNO, EANO and SNO contribute equally), will be also held in May 2017 and hope we make a good contribution there as well with good number of abstracts etc.
Finally, I would like to thank all of you and innumerable well wishers both in the country and overseas to help nurture our cause and wish our society the best to accomplish the goals it has set itself to. Please feel forward to write and contact me and any of our EC members with your suggestions and how best we can further improve our work, to make both the science as well as patients with brain tumours lead better and healthier lives.